The Role of Patent Foramen Ovale Closure in the Secondary Prevention of Cryptogenic Stroke: a Meta-Analysis Report

Abstract Background: Patent foramen ovale (PFO) closure has been compared to medical therapy for secondary prevention of recurrent cryptogenic stroke. Objectives: To produce an updated meta-analysis including only data from the primary analyses of clinical trials and to evaluate the role of PFO closure in the secondary prevention of recurrent stroke. Methods: Search in Medline (PubMed) and in ISI Web of Knowledge. Parameters under analysis and meta-analyses were: stroke, transient ischemic attack (TIA) and atrial fibrillation (AF). Comprehensive Meta-analysis Software V.2.0 (Biostat) was used. Random-effects analyses were carried out. A level of significance of 5% was used. Results: In this study six, randomized trials enrolling 3,750 patients were included. Unlike other published meta-analyses on the same topic, in this case, only clinical trial data, and not follow-up data, were used. PFO closure, as compared with medical therapy alone, demonstrated superiority in reducing the rate of recurrent stroke (risk ratio with PFO closure vs. medical therapy, 0.37; 95% confidence interval [CI], 0.17 to 0.78; p = 0.01). PFO closure did not offer a significant benefit in prevention of TIA (risk ratio with PFO closure vs. medical therapy, 0.96; 95% CI, 0.64 to 1.44; p = 0.85). Among patients assigned to closure group, an increased risk of atrial fibrillation was seen (risk ratio with PFO closure vs. medical therapy, 4.64; 95% CI, 2.38 to 9.01; p < 0.01). Conclusions: In patients with cryptogenic stroke who had a patent foramen ovale, a protective effect of closure was seen concerning the risk of recurrent stroke, but not regarding the prevention of TIA.

Saved in:
Bibliographic Details
Main Authors: Pereira,Sónia P. Pinto, Nunes,Alzira, Santos,Cristina, Kasner,Scott E, Nunes,José P. L
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Cardiologia 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472020000400307
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2359-56472020000400307
record_format ojs
spelling oai:scielo:S2359-564720200004003072020-08-03The Role of Patent Foramen Ovale Closure in the Secondary Prevention of Cryptogenic Stroke: a Meta-Analysis ReportPereira,Sónia P. PintoNunes,AlziraSantos,CristinaKasner,Scott ENunes,José P. L Foramen Ovale Patent/Diagnosis Stroke Isquemic Attack, Transient Atrial Fibrillation Risk Factors Stroke/Prevention and control Abstract Background: Patent foramen ovale (PFO) closure has been compared to medical therapy for secondary prevention of recurrent cryptogenic stroke. Objectives: To produce an updated meta-analysis including only data from the primary analyses of clinical trials and to evaluate the role of PFO closure in the secondary prevention of recurrent stroke. Methods: Search in Medline (PubMed) and in ISI Web of Knowledge. Parameters under analysis and meta-analyses were: stroke, transient ischemic attack (TIA) and atrial fibrillation (AF). Comprehensive Meta-analysis Software V.2.0 (Biostat) was used. Random-effects analyses were carried out. A level of significance of 5% was used. Results: In this study six, randomized trials enrolling 3,750 patients were included. Unlike other published meta-analyses on the same topic, in this case, only clinical trial data, and not follow-up data, were used. PFO closure, as compared with medical therapy alone, demonstrated superiority in reducing the rate of recurrent stroke (risk ratio with PFO closure vs. medical therapy, 0.37; 95% confidence interval [CI], 0.17 to 0.78; p = 0.01). PFO closure did not offer a significant benefit in prevention of TIA (risk ratio with PFO closure vs. medical therapy, 0.96; 95% CI, 0.64 to 1.44; p = 0.85). Among patients assigned to closure group, an increased risk of atrial fibrillation was seen (risk ratio with PFO closure vs. medical therapy, 4.64; 95% CI, 2.38 to 9.01; p < 0.01). Conclusions: In patients with cryptogenic stroke who had a patent foramen ovale, a protective effect of closure was seen concerning the risk of recurrent stroke, but not regarding the prevention of TIA.info:eu-repo/semantics/openAccessSociedade Brasileira de CardiologiaInternational Journal of Cardiovascular Sciences v.33 n.4 20202020-07-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472020000400307en10.36660/ijcs.20190075
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Pereira,Sónia P. Pinto
Nunes,Alzira
Santos,Cristina
Kasner,Scott E
Nunes,José P. L
spellingShingle Pereira,Sónia P. Pinto
Nunes,Alzira
Santos,Cristina
Kasner,Scott E
Nunes,José P. L
The Role of Patent Foramen Ovale Closure in the Secondary Prevention of Cryptogenic Stroke: a Meta-Analysis Report
author_facet Pereira,Sónia P. Pinto
Nunes,Alzira
Santos,Cristina
Kasner,Scott E
Nunes,José P. L
author_sort Pereira,Sónia P. Pinto
title The Role of Patent Foramen Ovale Closure in the Secondary Prevention of Cryptogenic Stroke: a Meta-Analysis Report
title_short The Role of Patent Foramen Ovale Closure in the Secondary Prevention of Cryptogenic Stroke: a Meta-Analysis Report
title_full The Role of Patent Foramen Ovale Closure in the Secondary Prevention of Cryptogenic Stroke: a Meta-Analysis Report
title_fullStr The Role of Patent Foramen Ovale Closure in the Secondary Prevention of Cryptogenic Stroke: a Meta-Analysis Report
title_full_unstemmed The Role of Patent Foramen Ovale Closure in the Secondary Prevention of Cryptogenic Stroke: a Meta-Analysis Report
title_sort role of patent foramen ovale closure in the secondary prevention of cryptogenic stroke: a meta-analysis report
description Abstract Background: Patent foramen ovale (PFO) closure has been compared to medical therapy for secondary prevention of recurrent cryptogenic stroke. Objectives: To produce an updated meta-analysis including only data from the primary analyses of clinical trials and to evaluate the role of PFO closure in the secondary prevention of recurrent stroke. Methods: Search in Medline (PubMed) and in ISI Web of Knowledge. Parameters under analysis and meta-analyses were: stroke, transient ischemic attack (TIA) and atrial fibrillation (AF). Comprehensive Meta-analysis Software V.2.0 (Biostat) was used. Random-effects analyses were carried out. A level of significance of 5% was used. Results: In this study six, randomized trials enrolling 3,750 patients were included. Unlike other published meta-analyses on the same topic, in this case, only clinical trial data, and not follow-up data, were used. PFO closure, as compared with medical therapy alone, demonstrated superiority in reducing the rate of recurrent stroke (risk ratio with PFO closure vs. medical therapy, 0.37; 95% confidence interval [CI], 0.17 to 0.78; p = 0.01). PFO closure did not offer a significant benefit in prevention of TIA (risk ratio with PFO closure vs. medical therapy, 0.96; 95% CI, 0.64 to 1.44; p = 0.85). Among patients assigned to closure group, an increased risk of atrial fibrillation was seen (risk ratio with PFO closure vs. medical therapy, 4.64; 95% CI, 2.38 to 9.01; p < 0.01). Conclusions: In patients with cryptogenic stroke who had a patent foramen ovale, a protective effect of closure was seen concerning the risk of recurrent stroke, but not regarding the prevention of TIA.
publisher Sociedade Brasileira de Cardiologia
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472020000400307
work_keys_str_mv AT pereirasoniappinto theroleofpatentforamenovaleclosureinthesecondarypreventionofcryptogenicstrokeametaanalysisreport
AT nunesalzira theroleofpatentforamenovaleclosureinthesecondarypreventionofcryptogenicstrokeametaanalysisreport
AT santoscristina theroleofpatentforamenovaleclosureinthesecondarypreventionofcryptogenicstrokeametaanalysisreport
AT kasnerscotte theroleofpatentforamenovaleclosureinthesecondarypreventionofcryptogenicstrokeametaanalysisreport
AT nunesjosepl theroleofpatentforamenovaleclosureinthesecondarypreventionofcryptogenicstrokeametaanalysisreport
AT pereirasoniappinto roleofpatentforamenovaleclosureinthesecondarypreventionofcryptogenicstrokeametaanalysisreport
AT nunesalzira roleofpatentforamenovaleclosureinthesecondarypreventionofcryptogenicstrokeametaanalysisreport
AT santoscristina roleofpatentforamenovaleclosureinthesecondarypreventionofcryptogenicstrokeametaanalysisreport
AT kasnerscotte roleofpatentforamenovaleclosureinthesecondarypreventionofcryptogenicstrokeametaanalysisreport
AT nunesjosepl roleofpatentforamenovaleclosureinthesecondarypreventionofcryptogenicstrokeametaanalysisreport
_version_ 1756441616736845824